mesowatch
HomeAsbestos insurance liability lawsuit sent to Montana Supreme Court
divider

Asbestos insurance liability lawsuit sent to Montana Supreme Court

montana supreme court

The state of Montana won a district court lawsuit that ruled that National Indemnity Co. (NIC), an insurance company wholly owned by Berkshire Hathaway, was liable for almost $100 million in damages entitled to asbestos victims in the small mountain town of Libby.

This was ruled in 2018. Now, the Montana Supreme Court is set to hear this pending case to finally put to rest the lack of coverage NIC failed to commit when hired to protect the state government from specific liabilities related to asbestos exposure.

NIC was originally responsible for the payment of a full settlement, given the fact that the state was a client of the insurance company during July 1, 1973, and July 1, 1975.

Because of the dangers of asbestos exposure in a local vermiculite mine, the settlement was involved with claims related to the exposure. This settlement amount for the residents of Libby was estimated to be about $43 million to more than 200 victims.

John Sullivan, a private attorney representing Montana in this case, said that National Indemnity Co. had the mandate to represent the state when the asbestos victims brought their claims of injury in 2002. Sullivan said that the company failed to do so.

Critical health damage from asbestos exposure can take decades to develop, Sullivan said. Because of this long latency period, NIC should be held in further accountability to cover claims and cases that developed in the years after the insurance contract was up.

“For almost 20 years, NIC has been able to avoid its contractual duties to defend the state,” Sullivan said in a statement sent to The Missoulian newspaper. “NIC admits that loss is the reason the state has had to pay multi-millions of dollars to settle thousands of claims. Its duty to defend is triggered by notice of potential claims.”

The Montana Supreme Court is expected to hand down a decision in the case in 2021.

Michael McGrady

Reading Time: 1 mins

Published On: November 21, 2020

Michael McGrady - author

Michael McGrady is a critically acclaimed journalist based in the U.S. state of Colorado. He has an extensive background covering harm reduction and risk minimization topics within the realm of public health. You can find McGrady’s writing in outlets like Filter Magazine, Inside Sources, The South China Morning Post, and several others across the globe.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer